The global Anti-infectious Disease Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The USA market for Global Anti-infectious Disease Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Anti-infectious Disease Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Anti-infectious Disease Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Overview
This report provides a deep insight into the global Anti-infectious Disease Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-infectious Disease Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-infectious Disease Drugs market in any manner.
Global Anti-infectious Disease Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Aridis Pharmaceuticals
- AiCuris
- Sandoz
- Anhui Jingfang Medical Industry Co.,Ltd
- Beijing Double-Crane Pharmaceutical Co., Ltd.
- Abbott
- Spero Therapeutics
- Adlyfe, Inc.
- Advanced Life Sciences Holdings, Inc.
- Affinium Pharmaceuticals
- APP Pharmaceuticals
- Aquapharm Biodiscovery
- Basilea Pharmaceutica AG
- Biophage Pharma, Inc.
Market Segmentation (by Type)
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
- Antiparasitic Drugs
Market Segmentation (by Application)
- Hospital
- Institute of Medicine
- Clinic
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-infectious Disease Drugs Market
- Overview of the regional outlook of the Anti-infectious Disease Drugs Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical
scope of the report, market division standards, and market research methods.
Chapter 2 is an executive
summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-infectious Disease Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anti-infectious Disease Drugs
1.2 Key Market Segments
1.2.1 Anti-infectious Disease Drugs Segment by Type
1.2.2 Anti-infectious Disease Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anti-infectious Disease Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Anti-infectious Disease Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-infectious Disease Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anti-infectious Disease Drugs Market Competitive Landscape
3.1 Global Anti-infectious Disease Drugs Sales by Manufacturers (2019-2024)
3.2 Global Anti-infectious Disease Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-infectious Disease Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-infectious Disease Drugs Sales Sites, Area Served, Product Type
3.6 Anti-infectious Disease Drugs Market Competitive Situation and Trends
3.6.1 Anti-infectious Disease Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-infectious Disease Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anti-infectious Disease Drugs Industry Chain Analysis
4.1 Anti-infectious Disease Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anti-infectious Disease Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anti-infectious Disease Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-infectious Disease Drugs Sales Market Share by Type (2019-2024)
6.3 Global Anti-infectious Disease Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Anti-infectious Disease Drugs Price by Type (2019-2024)
7 Anti-infectious Disease Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-infectious Disease Drugs Market Sales by Application (2019-2024)
7.3 Global Anti-infectious Disease Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-infectious Disease Drugs Sales Growth Rate by Application (2019-2024)
8 Anti-infectious Disease Drugs Market Segmentation by Region
8.1 Global Anti-infectious Disease Drugs Sales by Region
8.1.1 Global Anti-infectious Disease Drugs Sales by Region
8.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-infectious Disease Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-infectious Disease Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-infectious Disease Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-infectious Disease Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-infectious Disease Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Aridis Pharmaceuticals
9.1.1 Aridis Pharmaceuticals Anti-infectious Disease Drugs Basic Information
9.1.2 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Overview
9.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Market Performance
9.1.4 Aridis Pharmaceuticals Business Overview
9.1.5 Aridis Pharmaceuticals Anti-infectious Disease Drugs SWOT Analysis
9.1.6 Aridis Pharmaceuticals Recent Developments
9.2 AiCuris
9.2.1 AiCuris Anti-infectious Disease Drugs Basic Information
9.2.2 AiCuris Anti-infectious Disease Drugs Product Overview
9.2.3 AiCuris Anti-infectious Disease Drugs Product Market Performance
9.2.4 AiCuris Business Overview
9.2.5 AiCuris Anti-infectious Disease Drugs SWOT Analysis
9.2.6 AiCuris Recent Developments
9.3 Sandoz
9.3.1 Sandoz Anti-infectious Disease Drugs Basic Information
9.3.2 Sandoz Anti-infectious Disease Drugs Product Overview
9.3.3 Sandoz Anti-infectious Disease Drugs Product Market Performance
9.3.4 Sandoz Anti-infectious Disease Drugs SWOT Analysis
9.3.5 Sandoz Business Overview
9.3.6 Sandoz Recent Developments
9.4 Anhui Jingfang Medical Industry Co.,Ltd
9.4.1 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Basic Information
9.4.2 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Overview
9.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Market Performance
9.4.4 Anhui Jingfang Medical Industry Co.,Ltd Business Overview
9.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments
9.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
9.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Basic Information
9.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Overview
9.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Market Performance
9.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Business Overview
9.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments
9.6 Abbott
9.6.1 Abbott Anti-infectious Disease Drugs Basic Information
9.6.2 Abbott Anti-infectious Disease Drugs Product Overview
9.6.3 Abbott Anti-infectious Disease Drugs Product Market Performance
9.6.4 Abbott Business Overview
9.6.5 Abbott Recent Developments
9.7 Spero Therapeutics
9.7.1 Spero Therapeutics Anti-infectious Disease Drugs Basic Information
9.7.2 Spero Therapeutics Anti-infectious Disease Drugs Product Overview
9.7.3 Spero Therapeutics Anti-infectious Disease Drugs Product Market Performance
9.7.4 Spero Therapeutics Business Overview
9.7.5 Spero Therapeutics Recent Developments
9.8 Adlyfe, Inc.
9.8.1 Adlyfe, Inc. Anti-infectious Disease Drugs Basic Information
9.8.2 Adlyfe, Inc. Anti-infectious Disease Drugs Product Overview
9.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Product Market Performance
9.8.4 Adlyfe, Inc. Business Overview
9.8.5 Adlyfe, Inc. Recent Developments
9.9 Advanced Life Sciences Holdings, Inc.
9.9.1 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Basic Information
9.9.2 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Overview
9.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Market Performance
9.9.4 Advanced Life Sciences Holdings, Inc. Business Overview
9.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments
9.10 Affinium Pharmaceuticals
9.10.1 Affinium Pharmaceuticals Anti-infectious Disease Drugs Basic Information
9.10.2 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Overview
9.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Market Performance
9.10.4 Affinium Pharmaceuticals Business Overview
9.10.5 Affinium Pharmaceuticals Recent Developments
9.11 APP Pharmaceuticals
9.11.1 APP Pharmaceuticals Anti-infectious Disease Drugs Basic Information
9.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Product Overview
9.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Product Market Performance
9.11.4 APP Pharmaceuticals Business Overview
9.11.5 APP Pharmaceuticals Recent Developments
9.12 Aquapharm Biodiscovery
9.12.1 Aquapharm Biodiscovery Anti-infectious Disease Drugs Basic Information
9.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Overview
9.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Market Performance
9.12.4 Aquapharm Biodiscovery Business Overview
9.12.5 Aquapharm Biodiscovery Recent Developments
9.13 Basilea Pharmaceutica AG
9.13.1 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Basic Information
9.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Overview
9.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Market Performance
9.13.4 Basilea Pharmaceutica AG Business Overview
9.13.5 Basilea Pharmaceutica AG Recent Developments
9.14 Biophage Pharma, Inc.
9.14.1 Biophage Pharma, Inc. Anti-infectious Disease Drugs Basic Information
9.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Overview
9.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Market Performance
9.14.4 Biophage Pharma, Inc. Business Overview
9.14.5 Biophage Pharma, Inc. Recent Developments
10 Anti-infectious Disease Drugs Market Forecast by Region
10.1 Global Anti-infectious Disease Drugs Market Size Forecast
10.2 Global Anti-infectious Disease Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-infectious Disease Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Anti-infectious Disease Drugs Market Size Forecast by Region
10.2.4 South America Anti-infectious Disease Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-infectious Disease Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anti-infectious Disease Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-infectious Disease Drugs by Type (2025-2030)
11.1.2 Global Anti-infectious Disease Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-infectious Disease Drugs by Type (2025-2030)
11.2 Global Anti-infectious Disease Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Anti-infectious Disease Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-infectious Disease Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-infectious Disease Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-infectious Disease Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-infectious Disease Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infectious Disease Drugs as of 2022)
Table 10. Global Market Anti-infectious Disease Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-infectious Disease Drugs Sales Sites and Area Served
Table 12. Manufacturers Anti-infectious Disease Drugs Product Type
Table 13. Global Anti-infectious Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-infectious Disease Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-infectious Disease Drugs Market Challenges
Table 22. Global Anti-infectious Disease Drugs Sales by Type (Kilotons)
Table 23. Global Anti-infectious Disease Drugs Market Size by Type (M USD)
Table 24. Global Anti-infectious Disease Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-infectious Disease Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Anti-infectious Disease Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-infectious Disease Drugs Market Size Share by Type (2019-2024)
Table 28. Global Anti-infectious Disease Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-infectious Disease Drugs Sales (Kilotons) by Application
Table 30. Global Anti-infectious Disease Drugs Market Size by Application
Table 31. Global Anti-infectious Disease Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-infectious Disease Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Anti-infectious Disease Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-infectious Disease Drugs Market Share by Application (2019-2024)
Table 35. Global Anti-infectious Disease Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-infectious Disease Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-infectious Disease Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Anti-infectious Disease Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-infectious Disease Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-infectious Disease Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-infectious Disease Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-infectious Disease Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Aridis Pharmaceuticals Anti-infectious Disease Drugs Basic Information
Table 44. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Overview
Table 45. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Aridis Pharmaceuticals Business Overview
Table 47. Aridis Pharmaceuticals Anti-infectious Disease Drugs SWOT Analysis
Table 48. Aridis Pharmaceuticals Recent Developments
Table 49. AiCuris Anti-infectious Disease Drugs Basic Information
Table 50. AiCuris Anti-infectious Disease Drugs Product Overview
Table 51. AiCuris Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AiCuris Business Overview
Table 53. AiCuris Anti-infectious Disease Drugs SWOT Analysis
Table 54. AiCuris Recent Developments
Table 55. Sandoz Anti-infectious Disease Drugs Basic Information
Table 56. Sandoz Anti-infectious Disease Drugs Product Overview
Table 57. Sandoz Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sandoz Anti-infectious Disease Drugs SWOT Analysis
Table 59. Sandoz Business Overview
Table 60. Sandoz Recent Developments
Table 61. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Basic Information
Table 62. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Overview
Table 63. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Anhui Jingfang Medical Industry Co.,Ltd Business Overview
Table 65. Anhui Jingfang Medical Industry Co.,Ltd Recent Developments
Table 66. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Basic Information
Table 67. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Overview
Table 68. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Beijing Double-Crane Pharmaceutical Co., Ltd. Business Overview
Table 70. Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments
Table 71. Abbott Anti-infectious Disease Drugs Basic Information
Table 72. Abbott Anti-infectious Disease Drugs Product Overview
Table 73. Abbott Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Abbott Business Overview
Table 75. Abbott Recent Developments
Table 76. Spero Therapeutics Anti-infectious Disease Drugs Basic Information
Table 77. Spero Therapeutics Anti-infectious Disease Drugs Product Overview
Table 78. Spero Therapeutics Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Spero Therapeutics Business Overview
Table 80. Spero Therapeutics Recent Developments
Table 81. Adlyfe, Inc. Anti-infectious Disease Drugs Basic Information
Table 82. Adlyfe, Inc. Anti-infectious Disease Drugs Product Overview
Table 83. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Adlyfe, Inc. Business Overview
Table 85. Adlyfe, Inc. Recent Developments
Table 86. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Basic Information
Table 87. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Overview
Table 88. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Advanced Life Sciences Holdings, Inc. Business Overview
Table 90. Advanced Life Sciences Holdings, Inc. Recent Developments
Table 91. Affinium Pharmaceuticals Anti-infectious Disease Drugs Basic Information
Table 92. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Overview
Table 93. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Affinium Pharmaceuticals Business Overview
Table 95. Affinium Pharmaceuticals Recent Developments
Table 96. APP Pharmaceuticals Anti-infectious Disease Drugs Basic Information
Table 97. APP Pharmaceuticals Anti-infectious Disease Drugs Product Overview
Table 98. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. APP Pharmaceuticals Business Overview
Table 100. APP Pharmaceuticals Recent Developments
Table 101. Aquapharm Biodiscovery Anti-infectious Disease Drugs Basic Information
Table 102. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Overview
Table 103. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Aquapharm Biodiscovery Business Overview
Table 105. Aquapharm Biodiscovery Recent Developments
Table 106. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Basic Information
Table 107. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Overview
Table 108. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Basilea Pharmaceutica AG Business Overview
Table 110. Basilea Pharmaceutica AG Recent Developments
Table 111. Biophage Pharma, Inc. Anti-infectious Disease Drugs Basic Information
Table 112. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Overview
Table 113. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Biophage Pharma, Inc. Business Overview
Table 115. Biophage Pharma, Inc. Recent Developments
Table 116. Global Anti-infectious Disease Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Anti-infectious Disease Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Anti-infectious Disease Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Anti-infectious Disease Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Anti-infectious Disease Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Anti-infectious Disease Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Anti-infectious Disease Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Anti-infectious Disease Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Anti-infectious Disease Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Anti-infectious Disease Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Anti-infectious Disease Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Anti-infectious Disease Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Anti-infectious Disease Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Anti-infectious Disease Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Anti-infectious Disease Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Anti-infectious Disease Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Anti-infectious Disease Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Anti-infectious Disease Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-infectious Disease Drugs Market Size (M USD), 2019-2030
Figure 5. Global Anti-infectious Disease Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Anti-infectious Disease Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-infectious Disease Drugs Market Size by Country (M USD)
Figure 11. Anti-infectious Disease Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers in 2023
Figure 13. Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-infectious Disease Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-infectious Disease Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-infectious Disease Drugs Market Share by Type
Figure 18. Sales Market Share of Anti-infectious Disease Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Anti-infectious Disease Drugs by Type in 2023
Figure 20. Market Size Share of Anti-infectious Disease Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-infectious Disease Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-infectious Disease Drugs Market Share by Application
Figure 24. Global Anti-infectious Disease Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-infectious Disease Drugs Sales Market Share by Application in 2023
Figure 26. Global Anti-infectious Disease Drugs Market Share by Application (2019-2024)
Figure 27. Global Anti-infectious Disease Drugs Market Share by Application in 2023
Figure 28. Global Anti-infectious Disease Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-infectious Disease Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-infectious Disease Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-infectious Disease Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-infectious Disease Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-infectious Disease Drugs Sales Market Share by Country in 2023
Figure 37. Germany Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-infectious Disease Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-infectious Disease Drugs Sales Market Share by Region in 2023
Figure 44. China Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-infectious Disease Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-infectious Disease Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-infectious Disease Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-infectious Disease Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-infectious Disease Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-infectious Disease Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-infectious Disease Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-infectious Disease Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-infectious Disease Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-infectious Disease Drugs Market Share Forecast by Application (2025-2030)
